Edition:
United Kingdom

People: Sino Biopharmaceutical Ltd (1177.HK)

1177.HK on Hong Kong Stock

7.80HKD
18 Apr 2019
Change (% chg)

HK$-0.17 (-2.13%)
Prev Close
HK$7.97
Open
HK$7.91
Day's High
HK$7.91
Day's Low
HK$7.71
Volume
36,620,754
Avg. Vol
69,001,823
52-wk High
HK$13.93
52-wk Low
HK$4.53

Tse, Y Y 

Ms. Tse Y Y serves as Executive Chairlady of the Board of the Company since 30 June, 2015. Miss Tse the Chairlady of the Board, an Executive Director, and the Chairman of the Executive Board Committee and the Nomination Committee, respectively, of the Company. Miss Tse is also a director of CT Tianqing and the vice chairlady of Beijing Tide. She holds a Bachelor Degree of Science in Economics from the Wharton School of University of Pennsylvania. Throughout her coursework, she focused on the study of Finance and Healthcare. Previously, she worked in the investment, finance and business development departments of several companies. As a new generation business leader, Miss Tse was recognized as one of the “Most Outstanding Business Women in China for 2018” by Forbe China online. Miss Tse is the daughter of Mr. Tse Ping and Ms. Cheng Cheung Ling, both being Executive Directors and substantial shareholders of the Company, and she is also a niece of each of Mr. Tse Hsin, an Executive Director of the Company, Ms. Chia Fai, Miss Tse Wun, and Mr. Tse Hsuan, Johnny, all being senior management of the Company.

Basic Compensation

Total Annual Compensation, HKD 8,855,000
Restricted Stock Award, HKD --
Long-Term Incentive Plans, HKD --
All Other, HKD 15,000
Fiscal Year Total, HKD 8,870,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Y Y Tse

8,870,000

Ping Tse

36,727,000

Cheung Ling Cheng

11,116,000

Minggang Wang

--

Chun Ling Li

--

Hsin Tse

2,180,000
As Of  31 Dec 2017